Agentic Market Research for Pharma: From Question to Deck in Days

 Agentic market research for pharma starts from a straightforward observation: the six-to-eight-week primary research cycle is not a law of nature. It is the product of sequential handoffs between disconnected systems — brief to vendor, vendor to fieldwork team, fieldwork team to analysis, analysis to deck build. Sagan Agents' Agentic Market Research module collapses those handoffs into a single end-to-end pipeline. A business question goes in. A finished strategy deck comes out. The timeline is measured in days, not months.

The Problem With the Current MR Cycle

The insights professional in a pharmaceutical commercial organization is managing a gap that widens every year. Brand teams and commercial operations generate ad hoc questions continuously. Competitive events do not wait for quarterly research cycles. When a competitor label expansion lands on a Friday morning, the brand team wants a read by Monday. The traditional research model — brief, vendor selection, study design, panel recruitment, fielding, analysis, deck build — cannot serve that timeline. The question gets answered by intuition, or not at all.

Generic AI tools address part of this gap. They can scan existing documents or generate a first-pass draft. But they cannot design a rigorous survey instrument, field it to a qualified HCP sample, analyze the results against historical benchmarks, and produce a deliverable that a brand director can take to a leadership review. That requires a purpose-built pipeline with a proprietary panel at its core.

How Does Agentic Market Research Work?

The pipeline runs in four automated stages.
Design: AI agents draft the survey instrument — methodology, sample design, audience targeting — drawing on best practices and the archive of past ZoomRx instruments. The platform presents the design for human review, modification, or approval.
Field: Research routes directly to ZoomRx's proprietary HCP and patient panels, spanning 30-plus specialties and trusted by 19 of the top 20 global pharma companies. Quantitative surveys run as survey-as-conversation, eliminating the traditional trade-off between depth and scale. Qualitative studies are AI-moderated, compressing a typical four-to-six-week qual fielding timeline to two to three days — ZoomRx fielded 50 AI-moderated interviews in a single weekend for a recent client engagement. Interim results stream back into the platform in real time.
Analyze: Automated cross-tabs, statistical tests, and open-end coding run as data comes in. The platform synthesizes results against the Data Archive and, where relevant, Market Simulator outputs — so new primary findings are grounded in existing knowledge rather than presented in isolation.
Deliver: The platform generates the complete deliverable — executive summary, detailed findings, presentation-ready slides — in the formats stakeholders already use.

Two Modes: Human-Led and AI-Driven

Agentic Market Research operates in two deployment modes. In human-led mode, a pharmaceutical insights professional inputs a business question. The platform designs the research and presents it for review. The user approves, adjusts, or redirects. From that approval, the pipeline runs without further manual intervention. In AI-driven mode, the platform's continuous market monitoring through ZoomRx Data Feeds and Data Archive gap detection identifies a new knowledge gap autonomously — a competitor action, a regulatory signal, a shift in physician sentiment that existing research does not cover — and deploys research to fill it without requiring human initiation. Results return directly into the intelligence system. This mode enables the closed-loop intelligence system described across Sagan Agents: the platform identifies what it does not know and fills its own gaps.

The Economics of Agentic vs Traditional Research

The cost case for pharma research cycle automation is specific and verifiable. In a traditional primary research study, sample costs represent approximately 15-30% of the total project budget. The remainder is professional services: study design, analysis, synthesis, and deliverable build. Agentic Market Research replaces the professional services cost, not just the sample. That is the economic difference between synthetic data approaches — which save only the sample portion — and a fully agentic pipeline.

 ZoomRx's internal modeling projects 35-45% cost reduction on primary studies delivered through the Agentic Market Research module. For a brand team spending $2.5 million per year on primary research, that translates to roughly $1 million in annual savings, with research delivered at a fraction of the traditional timeline.  

Closing the Continuous Intelligence Loop

Agentic Market Research is not a standalone tool. When a study closes, results reconcile automatically against simulation outputs and historical benchmarks from the Data Archive. The new primary data flows back into the archive, expanding the foundation for every future query. An answer produced today becomes context for a question asked next quarter. Research compounds instead of expiring in a folder.

For pharmaceutical insights teams managing accelerating demand against flat or shrinking budgets, this architecture represents a structural shift, not an incremental efficiency gain. To see the full pipeline in action, explore Sagan Agents. To discuss how agentic market research fits your current research program, reach out to the ZoomRx team.

Frequently Asked Questions